Clover Health Investments Price to Book Ratio 2020-2025 | CLOV
Historical price to book ratio values for Clover Health Investments (CLOV) over the last 10 years. The current price to book ratio for Clover Health Investments as of July 22, 2025 is 4.85.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Clover Health Investments Price/Book Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | Book Value per Share | Price to Book Ratio |
| 2025-07-22 | 3.22 | 4.85 | |
| 2025-03-31 | 3.59 | $0.66 | 5.41 |
| 2024-12-31 | 3.15 | $0.68 | 4.65 |
| 2024-09-30 | 2.82 | $0.68 | 4.12 |
| 2024-06-30 | 1.23 | $0.65 | 1.88 |
| 2024-03-31 | 0.79 | $0.59 | 1.35 |
| 2023-12-31 | 0.95 | $0.59 | 1.63 |
| 2023-09-30 | 1.08 | $0.66 | 1.63 |
| 2023-06-30 | 0.90 | $0.68 | 1.31 |
| 2023-03-31 | 0.85 | $0.67 | 1.26 |
| 2022-12-31 | 0.93 | $0.75 | 1.25 |
| 2022-09-30 | 1.70 | $0.82 | 2.07 |
| 2022-06-30 | 2.14 | $0.89 | 2.39 |
| 2022-03-31 | 3.55 | $1.03 | 3.43 |
| 2021-12-31 | 3.72 | $1.15 | 3.25 |
| 2021-09-30 | 7.39 | $0.98 | 7.54 |
| 2021-06-30 | 13.15 | $0.77 | 17.05 |
| 2021-03-31 | 7.46 | $1.44 | 5.17 |
| 2020-12-31 | 16.55 | $-6.87 | -2.41 |
| 2020-09-30 | 12.30 | $0.21 | 59.59 |
| 2020-06-30 | 11.04 | $0.21 | 52.95 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.639B | $1.371B |
| Clover Health Investments Corp. is a healthcare technology company. It uses its proprietary technology platform to collect, structure and analyze health and behavioral data to improve medical outcomes and lower costs for patients. Clover Health Investments Corp., formerly known as Social Capital Hedosophia Holdings Corp. III, is based in Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.605B | 59.29 |
| Hims & Hers Health (HIMS) | United States | $11.194B | 116.30 |
| Doximity (DOCS) | United States | $11.153B | 51.63 |
| Tempus AI (TEM) | United States | $10.574B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $4.258B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $3.817B | 59.65 |
| Hinge Health (HNGE) | United States | $3.642B | 0.00 |
| Privia Health (PRVA) | United States | $2.447B | 167.25 |
| Schrodinger (SDGR) | United States | $1.671B | 0.00 |
| 10x Genomics (TXG) | United States | $1.600B | 0.00 |
| Phreesia (PHR) | United States | $1.595B | 0.00 |
| Enovis (ENOV) | United States | $1.556B | 8.68 |
| Azenta (AZTA) | United States | $1.507B | 70.04 |
| Omnicell (OMCL) | United States | $1.324B | 23.35 |
| Evolent Health (EVH) | United States | $1.147B | 97.70 |
| Claritev (CTEV) | United States | $0.702B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.567B | 0.00 |
| Standard BioTools (LAB) | United States | $0.517B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.467B | 0.00 |
| Talkspace (TALK) | United States | $0.435B | 130.00 |
| TruBridge (TBRG) | United States | $0.336B | 745.67 |
| Outset Medical (OM) | United States | $0.336B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.274B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.266B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.229B | 0.00 |
| CapsoVision (CV) | United States | $0.204B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.173B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.158B | 0.00 |
| Pulmonx (LUNG) | United States | $0.130B | 0.00 |
| American Well (AMWL) | United States | $0.128B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.114B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.112B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.89 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.081B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.078B | 0.00 |
| 111 (YI) | China | $0.064B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.053B | 0.00 |
| HeartBeam (BEAT) | United States | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.026B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.021B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.008B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |